Literature DB >> 6235165

Malignant "triton" tumors: a clinicopathologic and immunohistochemical study of nine cases.

Y Daimaru, H Hashimoto, M Enjoji.   

Abstract

Nine cases of malignant "triton" tumors, based on the coexistence of rhabdomyoblasts and Schwann cell elements, were analyzed clinicopathologically and immunocytochemically. All tumors were stained for myoglobin and S-100 protein by the immunoperoxidase technique. Six of the nine patients were in the third or fourth decade of life. Six cases were associated with von Recklinghausen's disease, and the tumors in two cases grew along nerve trunks. The malignant tumors showed a predilection for the thigh and buttock. Six of the seven deaths occurred within two years of the initial treatments. Strongly positive staining for S-100 protein was observed in three tumors, with transitional zones between the sarcomas and peripheral neurofibroma-like areas, as well as in two tumors composed predominantly of rhabdomyoblastic elements. In four other cases the tumors were only weakly positive for protein S-100. Intracytoplasmic myoglobin was present in all cases. Tumors composed predominantly of rhabdomyosarcomatous elements occurred in four patients, including two children with von Recklinghausen's disease. These results, considered with other findings, suggest that malignant "triton" tumors may not be as rare as previously believed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235165     DOI: 10.1016/s0046-8177(84)80169-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  19 in total

1.  Analysis of clinical features and prognosis of malignant triton tumor: A report of two cases and literature review.

Authors:  Guo Li; Chao Liu; Yong Liu; Fang Xu; Zhongwu Su; Yunyun Wang; Shuling Ren; Tengbo Deng; Donghai Huang; Yongquan Tian; Yuanzheng Qiu
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

2.  Malignant triton tumor: Grand Round presentation of a rare aggressive case thoracolumbar spine tumor.

Authors:  Soufiane Ghailane; Sandra Fauquier; Sébastien Lepreux; Jean-Charles Le Huec
Journal:  Eur Spine J       Date:  2017-09-18       Impact factor: 3.134

3.  Surgery for Peripheral Nerve Sheath Tumours of the Buttocks, Legs and Feet in 90 Patients With Neurofibromatosis Type 1.

Authors:  Reinhard E Friedrich; Caglayan T Tuzcu
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

4.  Malignant triton tumor: a rare case.

Authors:  Prasad K Shetty; Sameer V Baliga; Kopparthi Balaiah
Journal:  Indian J Surg       Date:  2012-07-28       Impact factor: 0.656

5.  Malignant triton tumor of the chest wall invading the lung. A case report and literature review.

Authors:  E Kamperis; N Barbetakis; C Asteriou; A Kleontas; V Christoforidou
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

6.  Malignant "triton" tumor in the thyroid--a case report.

Authors:  T Naruse; A Koike; K Suzumura; K Matsumoto; Y Inamura; J Saigusa
Journal:  Jpn J Surg       Date:  1991-07

7.  Ulnar malignant peripheral nerve sheath tumour diagnosis in a mixed-breed dog as a model to study human: histologic, immunohistochemical, and clinicopathologic study.

Authors:  Abbas Tavasoly; Javad Javanbakht; Fariba Khaki; Ehsan Hosseini; Alimohammad Bahrami; Mehdi Aghamohammad Hassan; Mohammadmehdi Mirabad
Journal:  Diagn Pathol       Date:  2013-05-20       Impact factor: 2.644

Review 8.  Malignant triton tumor of the retroperitoneum: a case report and review of the literature.

Authors:  Zhiwei Li; Jie Xiang; Sheng Yan; Feng Gao; Shusen Zheng
Journal:  World J Surg Oncol       Date:  2012-05-30       Impact factor: 2.754

9.  A case of malignant epithelioid schwannoma arising on the face.

Authors:  D A Ross; K Schafler
Journal:  J R Soc Med       Date:  1992-04       Impact factor: 18.000

10.  Malignant Triton Tumors in Sisters with Clinical Neurofibromatosis Type 1.

Authors:  Basnet Alina; Jofre A Sebastian; Capo Gerardo
Journal:  Case Rep Oncol Med       Date:  2015-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.